1. <span id="izpls"></span>

    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Nonclinical Safety Evaluation
    Consulting Service
    Consulting Service

    For more questions, please click "Consult Now", a professional consultant will answer your questions.


    The evaluation center covers an area of more than 5,000 square meters, equipped with a complete set of advanced international instruments. There are 8 departments including the toxicology department, analysis department, clinical pathology department, quality assurance department and laboratory animal department, as well as two committees of laboratory animal ethics, occupational health and safety in the center. There are more than 50 R & D personnel and their professional background covers medicine, pharmacy, pharmacology, toxicology, biology, genetics, pathology, clinical testing, veterinary medicine, mechanical and electrical engineering, archival science, computer science. The core R & D personnel have experience in GLP for more than five years. In addition, the center has hired several NMPA (formerly CFDA) new drug review experts and USFDA new drug review experts as academic consultants.


    Service Content


    1.   Single dose toxicity test (rodent and non-rodent single dose toxicity test)

    Including median lethal dose (LD50), maximum tolerated dose, etc.


    2.   Repetitive dose toxicity test (rodent and non-rodent repetitive dose toxicity test)

      Oral repetitive dose toxicity test

      Intravenous injection (drip) repetitive dose toxicity test

      Percutem repetitive dose toxicity test

      Repetitive dose toxicity test by other route of medication (inhalation, subcutaneous injection, intraperitoneal implantation, etc.)


    3.   Safety pharmacology test (general pharmacology test)

    1)   Core combination test

      Effect test of test substanceon cardiovascular system and respiratory system of anesthetized animals

      Effect test of test substanceon spontaneous activity of mice

      Effect test of test substanceon mouse body coordination ability

      Effect test of test substanceon pentobarbital sodium induced mouse sleep test

    2)   Additional tests

      Additional tests on the centralnervous system (tests such as learning and memory, convulsions and spinal cordreflex)

      Additional test on the cardiovascular system (blood pressure, heart test, etc.)

      Additional test on the respiratory system (tidal volume, lung resistance, lung compliance, etc.)

    3)   Supplementary test

     Supplementary test of the test substance on the digestive system (gastrointestinal motility and gastrointestinal function test, bile excretion test, in vitro intestinal tubetest, etc.)

     Supplementary test of test substance on urinary system (urine composition, renal tubular excretion, glomerular filtration rate, etc.)

     Supplementary test of test substance on autonomic nervous system (Effects on contraction of pregnant uterus and non-pregnant uterus, etc.)


    4.  Genetic toxicity test

        ①  Micronucleus test in mammals

        ②  In vitro mammalian cell chromosome aberration test

        ③  Salmonella typhimurium reverse mutation test (Ames test)


    5.   Reproductive toxicity test

      Phase I test, fertility and early embryo developmental toxicity test

      Phase II test, embryo-fetal body toxicity test (teratogenicity test)

      Phase III test, developmental toxicity test before and after birth (perinatal toxicity test)


    6.   Drug toxicokinetics test

      Study on toxicokinetics of single dose toxicity test

      Study on toxicokinetics of repeated drug toxicity test

      Study on toxicokinetics of reproductive toxicity test

      Study on toxicokinetics of genetic toxicity test


    7.   Local toxicity test

    Carry out local toxicity tests on injections, skin medications, eye drops, ear drops, inhalation preparations, mucosal administration (nasal spray, lozenges, suppositories).


    8.   Immunotoxicity (allergic, photoallergic) and / or immunogenicity test

      Active Systemic Anaphylaxis Test in guinea Pig (ASA)

      Passive Systemic Anaphylaxis Test (PCA) in rats and guinea pigs

      Guinea Pig Buehler Skin Allergy Test (BT)

      Guinea Pig Maximization Test(GMPT)

      Active Skin Allergic Test (ACA)

      Skin Photoallergic Test

      Local Lymph Node Test

      Splenic lymphocyte Transformation test

      Select other relevant tests according to the characteristics of the test substance


    Monitoring Room

    SPF animal room corridor


    A corner of anatomy laboratory



    Functional laboratory

    Evaluation Center office corridor



    • Phone:400-0020-628
    • Address:Clinical Center:7th Floor, Building A, Vanke Cloud Plaza, 1933 Huaguan Road, Tianhe District, Guangzhou / Laboratory Address:No.62,Nanxiang One Road,Huangpu Disrict,Guangzhou
    Copyright ? Boji Medical Technology Co., Ltd. All Rights Reserved 粵ICP備13039920號 (粵)—非經營性—2020-0084 Powered by vancheer
    Copyright ? Boji Medical Technology Co., Ltd. All Rights Reserved 粵ICP備13039920號 (粵)—非經營性—2020-0084 Powered by vancheer
    JAPAN18XXXXHD VIDEOS日本